Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions

被引:2
作者
Chen, Hsin-Ting [1 ,4 ]
Zhang, Yulei [1 ,4 ]
Huang, Jie [1 ,2 ,4 ]
Sawant, Manali [2 ,4 ]
Smith, Matthew D. [1 ,4 ]
Rajagopal, Nandhini [5 ]
Desai, Alec A. [1 ,4 ]
Makowski, Emily [2 ,4 ]
Licari, Giuseppe [5 ]
Xie, Yunxuan [2 ,4 ]
Marlow, Michael S. [5 ]
Kumar, Sandeep [5 ]
Tessier, Peter M. [1 ,2 ,3 ,4 ]
机构
[1] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA
[5] Boehringer Ingelheim Pharmaceut Inc, Biotherapeut Discovery, 900 Ridgebury Rd, Ridgefield, CT 06877 USA
来源
CELL REPORTS | 2024年 / 43卷 / 10期
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
NONSPECIFIC-BINDING; SURFACE DISPLAY; B-CELLS; AFFINITY; SPECIFICITY; CLEARANCE; AUTOREACTIVITY; CONSTRUCTION; PREDICTION; INFLUENZA;
D O I
10.1016/j.celrep.2024.114801
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although antibody variable regions mediate antigen-specific binding, they can also mediate non-specific interactions with non-cognate antigens, impacting diverse immunological processes and the efficacy, safety, and half-life of antibody therapeutics. To understand the molecular basis of antibody non-specificity, we sorted two dissimilar human na & imath;<spacing diaeresis>ve antibody libraries against multiple reagents to enrich for variants with different levels of polyreactivity. Sequence analysis of >300,000 paired antibody variable regions revealed that the heavy chain primarily mediates human antibody polyreactivity, and this is due to the high positive charge, high hydrophobicity, and combinations thereof in the corresponding complementaritydetermining regions, which can be predicted using a machine learning model developed in this work. Notably, a subset of the most important features governing antibody non-specific interactions, namely those that contain tyrosine, also govern specific antigen recognition. Our findings are broadly relevant for understanding fundamental aspects of antibody molecular recognition and the applied aspects of antibody-drug design.
引用
收藏
页数:21
相关论文
共 66 条
[1]   Non-specificity as the sticky problem in therapeutic antibody development [J].
Ausserwoger, Hannes ;
Schneider, Matthias M. ;
Herling, Therese W. ;
Arosio, Paolo ;
Invernizzi, Gaetano ;
Knowles, Tuomas P. J. ;
Lorenzen, Nikolai .
NATURE REVIEWS CHEMISTRY, 2022, 6 (12) :844-861
[2]   Sequence periodicity and secondary structure propensity in model proteins [J].
Bellesia, Giovanni ;
Jewett, Andrew Iain ;
Shea, Joan-Emma .
PROTEIN SCIENCE, 2010, 19 (01) :141-154
[3]   The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies [J].
Birtalan, Sara ;
Zhang, Yingnan ;
Fellouse, Frederic A. ;
Shao, Lihua ;
Schaefer, Gabriele ;
Sidhu, Sachdev S. .
JOURNAL OF MOLECULAR BIOLOGY, 2008, 377 (05) :1518-1528
[4]   The functional capacity of the natural amino acids for molecular recognition [J].
Birtalan, Sara ;
Fisher, Robert D. ;
Sidhu, Sachdev S. .
MOLECULAR BIOSYSTEMS, 2010, 6 (07) :1186-1194
[5]   Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops [J].
Boughter, Christopher T. ;
Borowska, Marta T. ;
Guthmiller, Jenna J. ;
Bendelac, Albert ;
Wilson, Patrick C. ;
Roux, Benoit ;
Adams, Erin J. .
ELIFE, 2020, 9 :1-47
[6]   Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses [J].
Burton, Dennis R. ;
Poignard, Pascal ;
Stanfield, Robyn L. ;
Wilson, Ian A. .
SCIENCE, 2012, 337 (6091) :183-186
[7]   Isolating and engineering human antibodies using yeast surface display [J].
Chao, Ginger ;
Lau, Wai L. ;
Hackel, Benjamin J. ;
Sazinsky, Stephen L. ;
Lippow, Shaun M. ;
Wittrup, K. Dane .
NATURE PROTOCOLS, 2006, 1 (02) :755-768
[8]   Tackling influenza with broadly neutralizing antibodies [J].
Corti, Davide ;
Cameroni, Elisabetta ;
Guarino, Barbara ;
Kallewaard, Nicole L. ;
Zhu, Qing ;
Lanzavecchia, Antonio .
CURRENT OPINION IN VIROLOGY, 2017, 24 :60-69
[9]   Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns [J].
Cunningham, Orla ;
Scott, Martin ;
Zhou, Zhaohui Sunny ;
Finlay, William J. J. .
MABS, 2021, 13 (01)
[10]   The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies [J].
Datta-Mannan, Amita ;
Lu, Jirong ;
Witcher, Derrick R. ;
Leung, Donmienne ;
Tang, Ying ;
Wroblewski, Victor J. .
MABS, 2015, 7 (06) :1084-1093